Functional genomics and the breast cancer problem

Tan Ince, Robert A. Weinberg

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The clinical treatment of primary breast cancers has been greatly complicated by the inability to accurately predict which tumors will eventually become invasive and metastatic and which will remain localized and indolent. Lacking the ability to discriminate between these two classes of breast cancer patients, oncologists often apply aggressive adjuvant therapy to women in both groups. However, the use of functional genomics analysis has now made it possible to assemble a set of gene markers, the expression of which enables one to predict, with reasonably high accuracy, whether or not the patient will relapse or remain tumor-free five years after initial diagnosis and treatment.

Original languageEnglish
Pages (from-to)15-17
Number of pages3
JournalCancer Cell
Volume1
Issue number1
DOIs
StatePublished - Feb 1 2002
Externally publishedYes

Fingerprint

Genomics
Breast Neoplasms
Neoplasms
Therapeutics
Gene Expression
Recurrence

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

Functional genomics and the breast cancer problem. / Ince, Tan; Weinberg, Robert A.

In: Cancer Cell, Vol. 1, No. 1, 01.02.2002, p. 15-17.

Research output: Contribution to journalArticle

Ince, Tan ; Weinberg, Robert A. / Functional genomics and the breast cancer problem. In: Cancer Cell. 2002 ; Vol. 1, No. 1. pp. 15-17.
@article{72d9d5a9bc24406d967a51616a4450ce,
title = "Functional genomics and the breast cancer problem",
abstract = "The clinical treatment of primary breast cancers has been greatly complicated by the inability to accurately predict which tumors will eventually become invasive and metastatic and which will remain localized and indolent. Lacking the ability to discriminate between these two classes of breast cancer patients, oncologists often apply aggressive adjuvant therapy to women in both groups. However, the use of functional genomics analysis has now made it possible to assemble a set of gene markers, the expression of which enables one to predict, with reasonably high accuracy, whether or not the patient will relapse or remain tumor-free five years after initial diagnosis and treatment.",
author = "Tan Ince and Weinberg, {Robert A.}",
year = "2002",
month = "2",
day = "1",
doi = "10.1016/S1535-6108(02)00023-5",
language = "English",
volume = "1",
pages = "15--17",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Functional genomics and the breast cancer problem

AU - Ince, Tan

AU - Weinberg, Robert A.

PY - 2002/2/1

Y1 - 2002/2/1

N2 - The clinical treatment of primary breast cancers has been greatly complicated by the inability to accurately predict which tumors will eventually become invasive and metastatic and which will remain localized and indolent. Lacking the ability to discriminate between these two classes of breast cancer patients, oncologists often apply aggressive adjuvant therapy to women in both groups. However, the use of functional genomics analysis has now made it possible to assemble a set of gene markers, the expression of which enables one to predict, with reasonably high accuracy, whether or not the patient will relapse or remain tumor-free five years after initial diagnosis and treatment.

AB - The clinical treatment of primary breast cancers has been greatly complicated by the inability to accurately predict which tumors will eventually become invasive and metastatic and which will remain localized and indolent. Lacking the ability to discriminate between these two classes of breast cancer patients, oncologists often apply aggressive adjuvant therapy to women in both groups. However, the use of functional genomics analysis has now made it possible to assemble a set of gene markers, the expression of which enables one to predict, with reasonably high accuracy, whether or not the patient will relapse or remain tumor-free five years after initial diagnosis and treatment.

UR - http://www.scopus.com/inward/record.url?scp=0036463714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036463714&partnerID=8YFLogxK

U2 - 10.1016/S1535-6108(02)00023-5

DO - 10.1016/S1535-6108(02)00023-5

M3 - Article

C2 - 12086883

AN - SCOPUS:0036463714

VL - 1

SP - 15

EP - 17

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 1

ER -